The ADCs segment held the largest market share in the historical period and is projected to hold a market share of over 50% by 2025. The Fc engineered antibodies segmented is projected to witness the fastest growth during the forecast period.
Geographically, North America dominates the next-generation antibody therapeutics market due to growing R&D activities and technological advancements in antibody therapeutics in the region. In addition, the increasing prevalence of chronic diseases and growing healthcare expenditure are fueling the growth of the next-generation antibody therapeutics market in North America. Moreover, the increasing healthcare expenditure is driving the market for next-generation antibody therapeutics in North America.
In 2018, the global Next Generation Antibody Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Next Generation Antibody Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Antibody Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Bayer
Takeda Pharmaceuticals
Biogen
Seattle Genetics
ImmunoGen
Kyowa Hakko Kirin
Xencor
Dyax Corp

Market segment by Type, the product can be split into
Antibody Drug Conjugates (ADCs)
Bispecific Antibodies (BsAbs)
Fc Engineered Antibodies
Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Biosimilar Antibody (Ab) Products

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Next Generation Antibody Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Next Generation Antibody Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Next Generation Antibody Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.